VanEck Associates’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Sell |
107,451
-635,968
| -86% | -$6.16M | ﹤0.01% | 1045 |
|
|
2025
Q1 | $11.1M | Buy |
743,419
+213,937
| +40% | +$3.19M | 0.01% | 451 |
|
|
2024
Q4 | $7.9M | Buy |
529,482
+252,750
| +91% | +$3.77M | 0.01% | 534 |
|
|
2024
Q3 | $4.76M | Buy |
276,732
+67,451
| +32% | +$1.16M | 0.01% | 663 |
|
|
2024
Q2 | $4.33M | Buy |
209,281
+37,371
| +22% | +$774K | 0.01% | 629 |
|
|
2024
Q1 | $3.23M | Sell |
171,910
-73,681
| -30% | -$1.39M | ﹤0.01% | 724 |
|
|
2023
Q4 | $3.54M | Sell |
245,591
-57,588
| -19% | -$830K | 0.01% | 638 |
|
|
2023
Q3 | $5.26M | Sell |
303,179
-91,614
| -23% | -$1.59M | 0.01% | 490 |
|
|
2023
Q2 | $8.22M | Buy |
394,793
+130,590
| +49% | +$2.72M | 0.02% | 385 |
|
|
2023
Q1 | $6.21M | Sell |
264,203
-192,039
| -42% | -$4.52M | 0.01% | 439 |
|
|
2022
Q4 | $12.7M | Buy |
456,242
+42,464
| +10% | +$1.19M | 0.03% | 303 |
|
|
2022
Q3 | $9.68M | Sell |
413,778
-195,486
| -32% | -$4.57M | 0.03% | 314 |
|
|
2022
Q2 | $20.6M | Buy |
609,264
+281,032
| +86% | +$9.48M | 0.05% | 239 |
|
|
2022
Q1 | $11.5M | Sell |
328,232
-9,306
| -3% | -$325K | 0.02% | 345 |
|
|
2021
Q4 | $10.3M | Buy |
337,538
+41,705
| +14% | +$1.27M | 0.02% | 370 |
|
|
2021
Q3 | $9.7M | Buy |
295,833
+106,368
| +56% | +$3.49M | 0.02% | 346 |
|
|
2021
Q2 | $5.73M | Buy |
+189,465
| New | +$5.73M | 0.01% | 442 |
|